Findings of Research Misconduct, 125 [2011-33651]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 1 / Tuesday, January 3, 2012 / Notices
Respondent agrees to maintain
responsibility for compliance with the
agreed upon supervision plan;
(2) that any institution employing her
shall submit, in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHS
supported research in which
Respondent is involved, a certification
to ORI that the data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology were
accurately reported in the application,
report, manuscript, or abstract; and
(3) to exclude herself from serving in
any advisory capacity to PHS including,
but not limited to, service on any PHS
advisory committee, board, and/or peer
review committee, or as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
John Dahlberg,
Director, Division of Investigative Oversight,
Office of Research Integrity.
[FR Doc. 2011–33650 Filed 12–30–11; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Mahesh Visvanathan, Ph.D., Kansas
University: Based on an inquiry
conducted and written admission
obtained by Kansas University (KU) and
additional analysis conducted by ORI in
its oversight review, ORI found that Dr.
Mahesh Visvanathan, Research
Assistant Professor in the K–INBRE 1
Bioinformatics Core Facility, KU,
engaged in research misconduct in
research supported by U.S. Public
Health Service (PHS) funds, specifically
the INBRE program of the National
Center for Research Resources (NCRR),
National Institutes of Health (NIH),
grant P20 RR016475.
Specifically, ORI found that
Respondent engaged in research
pmangrum on DSK3VPTVN1PROD with NOTICES
SUMMARY:
1 K–INBRE: The Kansas IDeA Network of
Biomedical Research Excellence, which is a
consortium of a number of schools and centers in
Kansas.
VerDate Mar<15>2010
15:13 Dec 30, 2011
Jkt 226001
misconduct by intentionally and
knowingly plagiarizing large amounts of
text from other writers’ published
papers without attribution or citation in
the following three (3) papers and one
(1) abstract. The specific published
documents as well as the relevant
source documents are:
• Visvanathan, M., Adagarla, B.,
Lushington, G., Sittampalam, S.,
Proceedings of the 2009 International
Joint Conference on Bioinformatics,
Systems, Biology and Intelligent
Computing, 2009, 494–497. Greater than
half (50%) of the total text was obtained
from (1) Yang, C.–S., Chuang, L.–Y., Ke,
C.–H., Yang, C.–H., International
Journal of Computer Science,
International Association of Engineers,
August 2008 35(3), (2) Goffard, N. and
Weiller, G., Nucleic Acids Research,
2007, 35L:W176– W18l, and (3) Chuang,
L.–Y., Yang, C.–H., Tu, C.–J., Yang, C.–
H., Proceedings of the Joint Conference
on Information Sciences, Atlantis Press,
October 2006.
Retracted: Retracted administratively
by IEEE on Jan 5, 2011 https://
ieeexplore.ieee.org/xpl/
freeabs_all.jsp?arnumber=5260432.
• Vijayan, A.; Skariah, B. E., Nair, B.;
Lushington, G., Subramanian, S.,
Visvanathan, M., Proceedings of the
IEEE International Conference on
Bioinformatics and Biomedicine
Workshop, 2009, BIBMW2009, 267–271.
Approximately 15%of the text was
plagiarized from Goffard, N. and
Weiller, G., Nucleic Acids Research,
2007, 35L:W176–W18l.
Retracted: Retracted administratively
by IEEE on Jan 5, 2011 https://
www.computer.org/portal/web/csdl/doi/
10.1109/BIBMW.2009.5332106.
• Visvanathan, M., Netzer, M., Seger,
M., Adagarla, B. S., Baumgartner, C.,
Sittampalam, S., Lushington, G.,
International Journal of Computational
Biology and Drug Design, 2009, 2,236–
251. A complete paragraph of the text
was plagiarized from Goffard, N. and
Weiller, G., Nucleic Acids Research,
2007, 35L:W176– W18l.
• Adagarla, B., Lushington, G.,
Visvanathan, M., ISMB International
Conference, January 2009; the entire
abstract for this poster was obtained by
plagiarizing text from Pihur, V., Datta,
S., Datta S., Genomics, 2003, 92:400–
403.
Dr. Visvanathan has entered into a
Voluntary Settlement Agreement
(Agreement) and has voluntarily agreed
for a period of two (2) years, beginning
on December 20, 2011:
(1) To have any PHS-supported
research supervised; ORI acknowledges
that Respondent’s research is currently
being supervised by KU; Respondent
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
125
shall ensure that a plan for supervision
of his PHS-related duties is submitted to
ORI for approval either within two
weeks of this Agreement becoming final
or prior to receiving or applying for PHS
funds if such support is not current at
the time this Agreement is completed;
the supervision plan must be designed
to ensure the scientific integrity of his
research contribution; because of the
ongoing review of Respondent’s
research by KU, ORI will only require a
summary report on the first and second
anniversary of the Agreement detailing
how KU has ensured that Respondent’s
research and language in PHS grant
applications and reports of PHSsupported research have been verified to
be his own and accurately reported;
Respondent agrees to maintain
responsibility for compliance with the
agreed upon supervision plan;
(2) That this annual summary,
provided by any institution employing
him, shall provide assurance that each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which
Respondent was involved, was based on
actual experiments or was otherwise
legitimately derived, that the data,
procedures, and methodology were
accurately reported in the application,
report, manuscript, or abstract, and that
the text in such submissions was his
own or properly cited the source of
copied language and ideas; and
(3) To exclude himself from serving in
any advisory capacity to PHS including,
but not limited to, service on any PHS
advisory committee, board, and/or peer
review committee, or as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852. (240) 453–8800.
John Dahlberg,
Director, Division of Investigative Oversight,
Office of Research Integrity.
[FR Doc. 2011–33651 Filed 12–30–11; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–D–0916]
Draft Guidance for Industry and Food
and Drug Administration Staff; Medical
Device Classification Product Codes;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
E:\FR\FM\03JAN1.SGM
Notice.
03JAN1
]]>Agencies
[Federal Register Volume 77, Number 1 (Tuesday, January 3, 2012)]
[Notices]
[Page 125]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33651]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has taken final action in the following case:
Mahesh Visvanathan, Ph.D., Kansas University: Based on an inquiry
conducted and written admission obtained by Kansas University (KU) and
additional analysis conducted by ORI in its oversight review, ORI found
that Dr. Mahesh Visvanathan, Research Assistant Professor in the K-
INBRE \1\ Bioinformatics Core Facility, KU, engaged in research
misconduct in research supported by U.S. Public Health Service (PHS)
funds, specifically the INBRE program of the National Center for
Research Resources (NCRR), National Institutes of Health (NIH), grant
P20 RR016475.
---------------------------------------------------------------------------
\1\ K-INBRE: The Kansas IDeA Network of Biomedical Research
Excellence, which is a consortium of a number of schools and centers
in Kansas.
---------------------------------------------------------------------------
Specifically, ORI found that Respondent engaged in research
misconduct by intentionally and knowingly plagiarizing large amounts of
text from other writers' published papers without attribution or
citation in the following three (3) papers and one (1) abstract. The
specific published documents as well as the relevant source documents
are:
Visvanathan, M., Adagarla, B., Lushington, G.,
Sittampalam, S., Proceedings of the 2009 International Joint Conference
on Bioinformatics, Systems, Biology and Intelligent Computing, 2009,
494-497. Greater than half (50%) of the total text was obtained from
(1) Yang, C.-S., Chuang, L.-Y., Ke, C.-H., Yang, C.-H., International
Journal of Computer Science, International Association of Engineers,
August 2008 35(3), (2) Goffard, N. and Weiller, G., Nucleic Acids
Research, 2007, 35L:W176- W18l, and (3) Chuang, L.-Y., Yang, C.-H., Tu,
C.-J., Yang, C.-H., Proceedings of the Joint Conference on Information
Sciences, Atlantis Press, October 2006.
Retracted: Retracted administratively by IEEE on Jan 5, 2011 https://ieeexplore.ieee.org/xpl/freeabs_all.jsp?arnumber=5260432.
Vijayan, A.; Skariah, B. E., Nair, B.; Lushington, G.,
Subramanian, S., Visvanathan, M., Proceedings of the IEEE International
Conference on Bioinformatics and Biomedicine Workshop, 2009, BIBMW2009,
267-271. Approximately 15%of the text was plagiarized from Goffard, N.
and Weiller, G., Nucleic Acids Research, 2007, 35L:W176-W18l.
Retracted: Retracted administratively by IEEE on Jan 5, 2011 https://www.computer.org/portal/web/csdl/doi/10.1109/BIBMW.2009.5332106.
Visvanathan, M., Netzer, M., Seger, M., Adagarla, B. S.,
Baumgartner, C., Sittampalam, S., Lushington, G., International Journal
of Computational Biology and Drug Design, 2009, 2,236-251. A complete
paragraph of the text was plagiarized from Goffard, N. and Weiller, G.,
Nucleic Acids Research, 2007, 35L:W176- W18l.
Adagarla, B., Lushington, G., Visvanathan, M., ISMB
International Conference, January 2009; the entire abstract for this
poster was obtained by plagiarizing text from Pihur, V., Datta, S.,
Datta S., Genomics, 2003, 92:400- 403.
Dr. Visvanathan has entered into a Voluntary Settlement Agreement
(Agreement) and has voluntarily agreed for a period of two (2) years,
beginning on December 20, 2011:
(1) To have any PHS-supported research supervised; ORI acknowledges
that Respondent's research is currently being supervised by KU;
Respondent shall ensure that a plan for supervision of his PHS-related
duties is submitted to ORI for approval either within two weeks of this
Agreement becoming final or prior to receiving or applying for PHS
funds if such support is not current at the time this Agreement is
completed; the supervision plan must be designed to ensure the
scientific integrity of his research contribution; because of the
ongoing review of Respondent's research by KU, ORI will only require a
summary report on the first and second anniversary of the Agreement
detailing how KU has ensured that Respondent's research and language in
PHS grant applications and reports of PHS-supported research have been
verified to be his own and accurately reported; Respondent agrees to
maintain responsibility for compliance with the agreed upon supervision
plan;
(2) That this annual summary, provided by any institution employing
him, shall provide assurance that each application for PHS funds, or
report, manuscript, or abstract involving PHS-supported research in
which Respondent was involved, was based on actual experiments or was
otherwise legitimately derived, that the data, procedures, and
methodology were accurately reported in the application, report,
manuscript, or abstract, and that the text in such submissions was his
own or properly cited the source of copied language and ideas; and
(3) To exclude himself from serving in any advisory capacity to PHS
including, but not limited to, service on any PHS advisory committee,
board, and/or peer review committee, or as a consultant.
FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite
750, Rockville, MD 20852. (240) 453-8800.
John Dahlberg,
Director, Division of Investigative Oversight, Office of Research
Integrity.
[FR Doc. 2011-33651 Filed 12-30-11; 8:45 am]
BILLING CODE 4150-31-P
